Moleculin Biotech, Inc. (MBRX) Flat As Market Gains: What You Should KnowZacks Investment Research • 05/05/20
Moleculin Rallies On Patent Applications That Could Give Cancer Drug 20 Years of ProtectionBenzinga • 07/10/19